Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in Elderly Diastolic Heart Failure
NCT00123955Phase 3Completed
- Sponsor
- Wake Forest University
- Start
- Apr 2005
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in heart failure with preserved ejection fraction (HFpEF) comparing Spironolactone with Placebo (2 arms). Primary endpoints: Exercise Intolerance at 9 months and Minnesota Living With Heart Failure Questionnaire Total Score at 9 months. Started Apr 2005; status: completed.
02
Drugs
spironolactone
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT00123955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123955.